MedPath

Bromocriptine mesylate

Bromocriptine Mesylate Tablets, USP

Approved
Approval ID

b89ff149-e33a-46cb-9649-64583e78a7ee

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 6, 2017

Manufacturers
FDA

Carilion Materials Management

DUNS: 079239644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Bromocriptine mesylate

PRODUCT DETAILS

NDC Product Code68151-1305
Application NumberANDA077646
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateSeptember 25, 2015
Generic NameBromocriptine mesylate

INGREDIENTS (7)

BROMOCRIPTINE MESYLATEActive
Quantity: 2.5 mg in 1 1
Code: FFP983J3OD
Classification: ACTIM
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MALEIC ACIDInactive
Code: 91XW058U2C
Classification: IACT
POVIDONE K25Inactive
Code: K0KQV10C35
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.